BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 32816225)

  • 1. Medulloblastoma epigenetics and the path to clinical innovation.
    Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
    J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
    Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics.
    Batora NV; Sturm D; Jones DT; Kool M; Pfister SM; Northcott PA
    Neuroscience; 2014 Apr; 264():171-85. PubMed ID: 23876321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.
    Gómez S; Garrido-Garcia A; Garcia-Gerique L; Lemos I; Suñol M; de Torres C; Kulis M; Pérez-Jaume S; Carcaboso ÁM; Luu B; Kieran MW; Jabado N; Kozlenkov A; Dracheva S; Ramaswamy V; Hovestadt V; Johann P; Jones DTW; Pfister SM; Morales La Madrid A; Cruz O; Taylor MD; Martin-Subero JI; Mora J; Lavarino C
    Clin Cancer Res; 2018 Mar; 24(6):1355-1363. PubMed ID: 29351917
    [No Abstract]   [Full Text] [Related]  

  • 6. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
    Li YX; Shao LW; Jiang T; Liu Y; Chang Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
    [No Abstract]   [Full Text] [Related]  

  • 7. Epigenetic regulation in medulloblastoma.
    Yi J; Wu J
    Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic events in medulloblastoma development.
    Lindsey JC; Anderton JA; Lusher ME; Clifford SC
    Neurosurg Focus; 2005 Nov; 19(5):E10. PubMed ID: 16398460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of microRNAs in medulloblastoma.
    Vidal DO; Marques MM; Lopes LF; Reis RM
    Pediatr Hematol Oncol; 2013 Aug; 30(5):367-78. PubMed ID: 23528184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
    Gupta T; Shirsat N; Jalali R
    Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
    Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
    Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
    Shiraishi R; Kawauchi D
    Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matching mice to malignancy: molecular subgroups and models of medulloblastoma.
    Lau J; Schmidt C; Markant SL; Taylor MD; Wechsler-Reya RJ; Weiss WA
    Childs Nerv Syst; 2012 Apr; 28(4):521-32. PubMed ID: 22315164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
    Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
    Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastoma biology in the post-genomic era.
    Archer TC; Pomeroy SL
    Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining the molecular substructure of medulloblastoma.
    Benmaamar R
    Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
    [No Abstract]   [Full Text] [Related]  

  • 17. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma.
    Kumar R; Smith KS; Deng M; Terhune C; Robinson GW; Orr BA; Liu APY; Lin T; Billups CA; Chintagumpala M; Bowers DC; Hassall TE; Hansford JR; Khuong-Quang DA; Crawford JR; Bendel AE; Gururangan S; Schroeder K; Bouffet E; Bartels U; Fisher MJ; Cohn R; Partap S; Kellie SJ; McCowage G; Paulino AC; Rutkowski S; Fleischhack G; Dhall G; Klesse LJ; Leary S; Nazarian J; Kool M; Wesseling P; Ryzhova M; Zheludkova O; Golanov AV; McLendon RE; Packer RJ; Dunham C; Hukin J; Fouladi M; Faria CC; Pimentel J; Walter AW; Jabado N; Cho YJ; Perreault S; Croul SE; Zapotocky M; Hawkins C; Tabori U; Taylor MD; Pfister SM; Klimo P; Boop FA; Ellison DW; Merchant TE; Onar-Thomas A; Korshunov A; Jones DTW; Gajjar A; Ramaswamy V; Northcott PA
    J Clin Oncol; 2021 Mar; 39(7):807-821. PubMed ID: 33502920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications.
    Arora I; Tollefsbol TO
    Methods; 2021 Mar; 187():92-103. PubMed ID: 32941995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid diagnosis of medulloblastoma molecular subgroups.
    Schwalbe EC; Lindsey JC; Straughton D; Hogg TL; Cole M; Megahed H; Ryan SL; Lusher ME; Taylor MD; Gilbertson RJ; Ellison DW; Bailey S; Clifford SC
    Clin Cancer Res; 2011 Apr; 17(7):1883-94. PubMed ID: 21325292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.